[New York] Specialty pharmacy updates
Summary
Anthem Blue Cross and Blue Shield in New York is implementing new prior authorization requirements for three specialty oncology medications (Avgemsi, Docivyx, Beizray) effective January 1, 2027. Additionally, step therapy requirements are being applied to pemetrexed, bendamustine, and docetaxel products, with specific formulations designated as preferred or non-preferred, requiring step therapy protocols before dispensing non-preferred agents.
Get alerts when payers change rules like this one
We check Anthem BCBS and other payers every day and email you when a change matches your specialty and state.